Hyperion Therapeutics Inc (HPTX) financial statements (2021 and earlier)

Company profile

Business Address 2000 SIERRA POINT PARKWAY
BRISBANE, CA 94005
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

3/31/2015
Q1
12/31/2014
Q4
9/30/2014
Q3
6/30/2014
Q2
3/31/2014
Q1
12/31/2013
Q4
9/30/2013
Q3
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments129137132123121102109
Cash and cash equivalents8910396818074109
Short-term investments403436424128 
Receivables22151719247
Inventory, net of allowances, customer advances and progress billings6543344
Inventory6543344
Other undisclosed current assets3321111
Total current assets:158159154146127112121
Noncurrent Assets
Property, plant and equipment1111111
Long-term investments and receivables25973416 
Long-term investments25973416 
Intangible assets, net (including goodwill)8910151121315
Goodwill   4   
Intangible assets, net (excluding goodwill)8910147121315
Other noncurrent assets3211110
Deferred tax assets, net   (3)   
Other undisclosed noncurrent assets   3   
Total noncurrent assets:372119156183116
TOTAL ASSETS:195180173302145143137
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities40353342161912
Accounts payable9587322
Accrued liabilities2726253111128
Employee-related liabilities34 3243
Taxes payable11 100 
Debt2  5666
Deferred revenue and credits000 0  
Other undisclosed current liabilities(4)(5) (3)(2)(5)(3)
Total current liabilities:38303343202015
Noncurrent Liabilities
Long-term debt and lease obligation1718181134
Long-term debt, excluding current maturities1718181134
Liabilities, other than long-term debt000000 
Deferred revenue and credits000000 
Other undisclosed noncurrent liabilities   107   
Total noncurrent liabilities:171818108234
Total liabilities:554951151222319
Stockholders' equity
Stockholders' equity attributable to parent140132122151123120118
Common stock0000000
Additional paid in capital262260258254244242241
Accumulated other comprehensive loss(0)(0)(0)(0)(0)(0) 
Accumulated deficit(121)(129)(136)(104)(121)(122)(123)
Total stockholders' equity:140132122151123120118
TOTAL LIABILITIES AND EQUITY:195180173302145143137

Income statement (P&L) ($ in millions)

3/31/2015
Q1
12/31/2014
Q4
9/30/2014
Q3
6/30/2014
Q2
3/31/2014
Q1
12/31/2013
Q4
9/30/2013
Q3
Revenues31312637191915
Revenue, net3131263719 17
Cost of revenue(4)(4)(3)(4)(2)(3)(3)
Gross profit:27272333171612
Operating expenses(23)(24)(55)(22)(18)(18)(15)
Other undisclosed operating income 434233
Operating income (loss):57(29)15210
Nonoperating income (expense)4(0)(0)0(0)00
Investment income, nonoperating0 00000
Other nonoperating income (expense)4 (0)(0)(0)00
Interest and debt expense(0)(0)(0)(0)(0)(0)(0)
Income (loss) from continuing operations before equity method investments, income taxes:96(29)15110
Other undisclosed income (loss) from continuing operations before income taxes00(1)  31 
Income (loss) from continuing operations before income taxes:96(30)151320
Income tax expense (benefit)(2)1(3)2(0)  
Other undisclosed loss from continuing operations     (0) 
Net income (loss):77(33)171320
Other undisclosed net loss attributable to parent     (31) 
Net income (loss) available to common stockholders, diluted:77(33)17100

Comprehensive Income ($ in millions)

3/31/2015
Q1
12/31/2014
Q4
9/30/2014
Q3
6/30/2014
Q2
3/31/2014
Q1
12/31/2013
Q4
9/30/2013
Q3
Net income (loss):77(33)171320
Other comprehensive income (loss)0(0)(0)00  
Other undisclosed comprehensive loss     (0) 
Comprehensive income (loss), net of tax, attributable to parent:77(33)171310

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: